Advertisement
Research Article| Volume 19, ISSUE 1, P157-168, March 1999

Download started.

Ok

Transient Myeloproliferative Disorder (Transient Leukemia) and Hematologic Manifestations of Down Syndrome

DOI:https://doi.org/10.1016/S0272-2712(18)30133-1
Transient Myeloproliferative Disorder (Transient Leukemia) and Hematologic Manifestations of Down Syndrome
Previous ArticleThe Histiocytoses
Next ArticleAcute Lymphoblastic Leukemia
      This paper is only available as a PDF. To read, Please Download here.
      Transient Myeloproliferative Disorder (Transient Leukemia) is found in approximately 10% of newborn infants with Down Syndrome. It is characterized by the large numbers of megakaryo-blasts in the peripheral blood, variable thrombocytopenia and, in a minority of cases, by a lethal course with hydrops fetalis or progressive hepatic fibrosis. Evidence is presented that this disease is truly leukemia, which, in most cases, recovers spontaneously. There is evidence that hematopoiesis is abnormal in Down Syndrome children who do not have leukemia. These abnormalities of red cells, platelets, and granulocytes are reviewed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Barroeta O.
        • Nungaray L.
        • Lopez-Osuna M.
        • et al.
        Defective monocyte chemotaxis in children with Down’s Syndrome.
        Pediatr Res. 1983; 17: 292-295
        • David O.
        • Fiorucci G.C.
        • Tosi M.T.
        • et al.
        Hematological studies in children with Down Syndrome.
        Pediatr Hematol Oncol. 1996; 13: 271-275
        • Djaldetti M.
        • Bessler H.
        • Fishman P.
        • et al.
        Ultrastructural features of the granulocytes in Down Syndrome.
        Scand J Haemat. 1974; 12: 104-111
        • Doyle J.J.
        • Thorner P.
        • Poon A.
        • et al.
        Transient Leukemia followed by megakaryoblastic Leukemia in a child with mosaic Down Syndrome.
        Leuk Lymphoma. 1995; 17: 345-350
        • Doyle J.J.
        • Zipursky A.
        Down Syndrome children with neonatal transient leukemia. Survival and risk of subsequent myelodysplasia and leukemia [abstract].
        Blood. 1994; 84: 316A
        • Fisher A.M.
        Are trisomy 21 fetuses subject to a myeloproliferation which is manifest in maternal blood.
        Prenat Diagn. 1997; 17: 885-886
        • Gericke G.S.
        • Hesseling P.B.
        • Brink S.
        • et al.
        Leucocyte ultrastructure and folate metabolism in Down’s syndrome.
        S Afr Med J. 1977; 51: 369-374
        • Homans A.C.
        • Verissimo A.M.
        • Vlacha V.
        Transient abnormal myelopoiesis of infancy associated with Trisomy 21.
        Am J Pediatr Hematol Oncol. 1993; 15: 392-399
        • Honda F.
        • Punnett H.H.
        • Charney E.
        • et al.
        Serial cytogenetic and hematologic studies on a mongol with trisomy 21 and acute congenital leukemia.
        J Pediatr. 1964; 65: 880-887
        • Kojima S.
        • Matsuyama T.
        • Sato T.
        • et al.
        Down’s syndrome and acute leukemia in children: An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
        Blood. 1990; 76: 2348-2353
        • Lampkin B.C.
        The newborn infant with leukemia.
        J Pediatr. 1997; 131: 176-177
        • Miller M.
        • Cosgriff J.M.
        Hematological abnormalities in newborn infants with Down Syndrome.
        Am J Med Genet. 1983; 16: 173-177
        • Mittwoch U.
        Frequency of drumsticks in normal women and in patients with chromosomal abnormalities.
        Nature. 1964; 201: 317-319
        • Miyauchi J.
        • Ito Y.
        • Kawano T.
        • et al.
        Unusual diffuse liver fibrosis accompanying transient abnormal myeloproliferative disorder in Down’s Syndrome: A report of four autopsy cases and proposal of a hypothesis.
        Blood. 1992; 80: 1521-1527
        • Robison L.L.
        • Nesbit M.E.
        • Sather H.N.
        • et al.
        Down syndrome and acute leukemia in children: A 10-year retrospective survey from Children’s Cancer Study Group.
        J Pediatr. 1984; 105: 235-242
        • Ruchelli E.D.
        • Uri A.
        • Dimmick J.E.
        • et al.
        Severe perinatal liver disease and Down Syndrome: An apparent relationship.
        Hum Pathol. 1991; 22: 1274-1280
        • Standen G.
        • Philip M.A.
        • Fletcher J.
        Reduced number of peripheral blood granulocytic progenitor cells in patients with Down’s Syndrome.
        Br J Haematol. 1979; 42: 417-423
        • Stare T.J.
        Erythrocyte macrocytosis in infants and children with Down Syndrome.
        J Pediatr. 1992; 121: 578-581
        • Thüring W.
        • Tönz O.
        Neonatale thrombozytenwerte bei kindern mit Down-syndrome and anderen autosomalen trisomien.
        Helv paediat Acta. 1979; 34: 545-555
        • Weinberger M.M.
        • Oleinick M.D.
        Congenital marrow dysfunction in Down’s Syndrome.
        J Pediatr. 1970; 77: 273-279
        • Yavuzyilmaz E.
        • Ersoy F.
        • Sanal O.
        • et al.
        Neutrophil chemotaxis and periodontal status in Down’s Syndrome patients.
        J Nihon Univ Sch Dent. 1993; 35: 91-95
        • Zipursky A.
        • Brown E.
        • Christensen H.
        • et al.
        Leukemia and/or Myeloproliferative syndrome in neonates with Down Syndrome.
        Semin Perinatol. 1997; 21: 97-101
        • Zipursky A.
        • Christensen H.
        • De Harven E.
        Ultrastructural studies of the megakaryo-blastic leukemias of Down Syndrome.
        Leuk Lymphoma. 1995; 18: 341-347
        • Zipursky A.
        • Doyle J.
        • Christensen H.
        • et al.
        Leukemic cells in the Transient Leukemia of Down Syndrome [abstract].
        Blood. 1992; 80: 32A
        • Zipursky A.
        • Doyle J.
        Leukemia in newborn infants with Down Syndrome.
        Leuk Res. 1993; 17: 195
        • Zipursky A.
        • Poon A.
        • Doyle J.
        Leukemia in Down Syndrome. A Review.
        Pediatr Hematol Oncol. 1992; 9: 139
        • Zipursky A.
        • Rose T.
        • Skidmore M.
        • et al.
        Hydrops fetalis and neonatal leukemia in Down Syndrome.
        Pediatr Hematol Oncol. 1996; 13: 81-87
        • Zipursky A.
        • Thorner P.
        • De Harven E.
        • et al.
        Myelodysplasia and acute megakaryoblastic leukemia in Down Syndrome.
        Leuk Lymphoma. 1994; 18: 163-171

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30133-1

      Copyright

      © 1999 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX